Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
| Autor: | Julien Favresse, Constant Gillot, Jonathan Douxfils, François Mullier |
|---|---|
| Přispěvatelé: | UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Laboratoire de biologie clinique |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) business.industry SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Vaccination COVID-19 Seroepidemiologic Studies Seroneutralization Virology Antibodies Neutralizing Specific antibody Infectious Diseases SARS-CoV-2 vaccination Seroprevalence Medicine Humans Immunological response business Letter to the Editor |
| Zdroj: | The Journal of Infection The Journal of infection, Vol. 83, no. 4, p. e4-e5 (2021) |
| ISSN: | 1532-2742 0163-4453 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect